The clinical impact of new left bundle branch block (LBBB) after transcatheter aortic valve replacement (TAVR) remains controversial and has not been studied in intermediate risk patients. We analyzed outcomes… Click to show full abstract
The clinical impact of new left bundle branch block (LBBB) after transcatheter aortic valve replacement (TAVR) remains controversial and has not been studied in intermediate risk patients. We analyzed outcomes associated with new LBBB in a large cohort of intermediate risk patients undergoing TAVR
               
Click one of the above tabs to view related content.